<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove Medical Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23847436</article-id>
      <article-id pub-id-type="pmc">3704548</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S41245</article-id>
      <article-id pub-id-type="publisher-id">nss-5-087</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Rapid Communication</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Ventricular orexin-A (hypocretin-1) levels correlate with rapid-eye-movement sleep without atonia in Parkinson’s disease</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bridoux</surname>
            <given-names>Agathe</given-names>
          </name>
          <xref ref-type="aff" rid="af1-nss-5-087">1</xref>
          <xref ref-type="aff" rid="af2-nss-5-087">2</xref>
          <xref ref-type="corresp" rid="c1-nss-5-087"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Moutereau</surname>
            <given-names>Stephane</given-names>
          </name>
          <xref ref-type="aff" rid="af3-nss-5-087">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Covali-Noroc</surname>
            <given-names>Ala</given-names>
          </name>
          <xref ref-type="aff" rid="af1-nss-5-087">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Margarit</surname>
            <given-names>Laurent</given-names>
          </name>
          <xref ref-type="aff" rid="af1-nss-5-087">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Palfi</surname>
            <given-names>Stephane</given-names>
          </name>
          <xref ref-type="aff" rid="af4-nss-5-087">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nguyen</surname>
            <given-names>Jean-Paul</given-names>
          </name>
          <xref ref-type="aff" rid="af5-nss-5-087">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lefaucheur</surname>
            <given-names>Jean-Pascal</given-names>
          </name>
          <xref ref-type="aff" rid="af1-nss-5-087">1</xref>
          <xref ref-type="aff" rid="af2-nss-5-087">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Césaro</surname>
            <given-names>Pierre</given-names>
          </name>
          <xref ref-type="aff" rid="af6-nss-5-087">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>d’Ortho</surname>
            <given-names>Marie-Pia</given-names>
          </name>
          <xref ref-type="aff" rid="af7-nss-5-087">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Drouot</surname>
            <given-names>Xavier</given-names>
          </name>
          <xref ref-type="aff" rid="af1-nss-5-087">1</xref>
          <xref ref-type="aff" rid="af2-nss-5-087">2</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-nss-5-087"><label>1</label>Service de Physiologie, Groupe Henri Mondor, Créteil, France</aff>
      <aff id="af2-nss-5-087"><label>2</label>Faculté de Médecine, Université Paris Est Créteil, Créteil, France</aff>
      <aff id="af3-nss-5-087"><label>3</label>Service de Biochimie, Groupe Henri Mondor, Créteil, France</aff>
      <aff id="af4-nss-5-087"><label>4</label>UF Neurochirurgie Fonctionnelle, Groupe Henri Mondor, Créteil, France</aff>
      <aff id="af5-nss-5-087"><label>5</label>Service de Neurochirurgie, Hôpital Nord Laënnec, Nantes, France</aff>
      <aff id="af6-nss-5-087"><label>6</label>Service de Neurologie, Groupe Henri Mondor, Créteil, France</aff>
      <aff id="af7-nss-5-087"><label>7</label>Service de Physiologie, Groupe Bichat – Claude Bernard, Paris, France</aff>
      <author-notes>
        <corresp id="c1-nss-5-087">Correspondence: Agathe Bridoux, Service de Physiologie Explorations Fonctionnelles, AP-HP, Groupe Hospitalier Henri Mondor – Albert Chenevier, Créteil F-94010, France, Tel +33 1 49 81 46 70, Fax +33 1 49 81 46 60, Email <email>agathe.bridoux@hmn.aphp.fr</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>6</month>
        <year>2013</year>
      </pub-date>
      <volume>5</volume>
      <fpage>87</fpage>
      <lpage>91</lpage>
      <permissions>
        <copyright-statement>© 2013 Bridoux et al, publisher and licensee Dove Medical Press Ltd</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license>
          <license-p>This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Objective</title>
          <p><citation_analysis attribute="positive">Patients with Parkinson’s disease frequently complain of sleep disturbances and loss of muscle atonia during rapid-eye-movement (REM) sleep is not rare. The orexin-A (hypocretin-1) hypothalamic system plays a central role in controlling REM sleep. Loss of orexin neurons results in narcolepsy-cataplexy, a condition characterized by diurnal sleepiness and REM sleep without atonia. Alterations in the orexin-A system have been also documented in Parkinson’s disease, but whether these alterations have clinical consequences remains unknown.</citation_analysis></p>
        </sec>
        <sec>
          <title>Methods</title>
          <p><citation_analysis attribute="neither">Here, we measured orexin-A levels in ventricular cerebrospinal fluid from eight patients with Parkinson’s disease (four males and four females) who underwent ventriculography during deep brain-stimulation surgery and performed full-night polysomnography before surgery.</citation_analysis></p>
        </sec>
        <sec>
          <title>Results</title>
          <p><citation_analysis attribute="positive">Our results showed a positive correlation between orexin-A levels and REM sleep without muscle atonia.</citation_analysis></p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p><citation_analysis attribute="neither">Our results suggest that high levels of orexin-A in Parkinson’s disease may be associated with loss of REM muscle atonia.</citation_analysis></p>
        </sec>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Parkinson</kwd>
        <kwd>orexin-A</kwd>
        <kwd>ventricular CSF</kwd>
        <kwd>REM atonia</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p><citation_analysis attribute="neither">Sleep disorders and diurnal sleepiness are frequent in Parkinson’s disease.</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b1-nss-5-087">1</xref></citation_analysis><citation_analysis attribute="positive"> Polysomnography studies have shown rapid-eye-movement (REM) sleep dysregulation with REM sleep onset on diurnal naps</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b2-nss-5-087">2</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b3-nss-5-087">3</xref></citation_analysis><citation_analysis attribute="neither"> and loss of muscle atonia,</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b4-nss-5-087">4</xref></citation_analysis><citation_analysis attribute="neither"> which is defined as “excessive amount of sustained or intermittent elevation of submental electromyographic tone or excessive phasic submental or limb electromyographic twitching.”</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b4-nss-5-087">4</xref></citation_analysis><citation_analysis attribute="neither"> Loss of REM atonia is a core phenomenon of REM sleep behavioral disorder (RBD),</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b5-nss-5-087">5</xref></citation_analysis><citation_analysis attribute="neither"> a condition characterized by vigorous and injurious motor behaviors during REM sleep.</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b6-nss-5-087">6</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">The orexin system plays a key role in REM sleep regulation. The loss of orexin neurons results in narcolepsy-cataplexy, a condition characterized by severe diurnal sleepiness, REM sleep onset during daytime naps, and cataplexies. REM sleep without atonia (RSWA) and RBD have also been reported to occur in narcolepsy.</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b7-nss-5-087">7</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">Orexin neurotransmission has been shown to be altered in Parkinson’s disease (PD).</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b8-nss-5-087">8</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b10-nss-5-087">10</xref></citation_analysis><citation_analysis attribute="neither"> However, polysomnographic data were not available in these postmortem studies. Furthermore, we showed that ventricular orexin levels were not correlated with mean sleep latency, suggesting that orexin deficit might not be involved in daytime sleepiness in PD.</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b11-nss-5-087">11</xref></citation_analysis><citation_analysis attribute="neither"> Thus, the clinical expression of orexin deficit in PD remains unknown.</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b12-nss-5-087">12</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">The objective of this study was to determine whether orexin-A levels in ventricular cerebrospinal fluid (CSF) from PD patients were correlated with REM sleep without atonia.</citation_analysis></p>
    </sec>
    <sec sec-type="methods">
      <title>Patients and methods</title>
      <sec sec-type="subjects">
        <title>Patients</title>
        <p><citation_analysis attribute="neither">Consecutive patients with idiopathic PD</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b13-nss-5-087">13</xref></citation_analysis><citation_analysis attribute="positive"> who were scheduled for deep brain-stimulation neurosurgery were invited to participate in the study, irrespective of whether they had sleep complaints. We did not include patients taking medications known to affect sleep or REM atonia or patients with sleep apnea syndrome defined as an apnea/hypopnea index greater than ten per hour of sleep. Disease severity was assessed based on the motor subscore of the Unified Parkinson’s Disease Rating Scale III after overnight withdrawal of dopaminergic treatment. The study was approved by the appropriate ethics committee, and informed consent was obtained from all patients prior to study inclusion.</citation_analysis></p>
      </sec>
      <sec>
        <title>Polysomnography</title>
        <p><citation_analysis attribute="positive">Sleep recordings were obtained during attended polysomnography 1 week before the scheduled date of neurosurgery. Polysomnography included electroencephalogram recordings (C4–A1, C3–A2, and O1–O2 leads), two electrooculograms, one submental electromyogram (EMG), and bilateral anterior tibialis EMGs. Also recorded were nasal pressure, oral airflow, thoracic and abdominal movements, and pulse oximetry. Video recordings were not obtained. Patients took their usual PD medications and were free to go to sleep when they wanted to.</citation_analysis></p>
        <p><citation_analysis attribute="neither">Sleep stages were scored by two sleep specialists who had extensive experience with recordings in PD patients (AB and XD), according to the modified American Academy of Sleep Medicine criteria,</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b14-nss-5-087">14</xref></citation_analysis><citation_analysis attribute="neither"> with allowance for RSWA. RSWA was scored as previously described by Lapierre and Montplaisir.</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b16-nss-5-087">16</xref></citation_analysis><citation_analysis attribute="neither"> Tonic chin-muscle activity during REM sleep was defined as chin EMG amplitude greater than twice the amplitude measured during a baseline EMG signal for atonia. Phasic EMG events were defined as any burst of activity lasting 0.3–5 seconds and having amplitude greater than four times the baseline EMG signal. Tonic and phasic EMG activities were scored from the submental EMG signal per 3-second mini-epochs of REM sleep containing or not containing “any” EMG activity (tonic, phasic, or a combination of both EMG activities).</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b17-nss-5-087">17</xref></citation_analysis><citation_analysis attribute="positive"> We then reported loss of REM atonia as the percentage of REM sleep mini-epochs with “any” EMG activity. Tonic and phasic EMG increases associated with respiratory arousals were excluded from the analysis.</citation_analysis></p>
      </sec>
      <sec>
        <title>Collection of ventricular cerebrospinal fluid</title>
        <p><citation_analysis attribute="neither">Ventriculography performed to assist in the proper placement of an electrode in the subthalamic nucleus require the removal of CSF just before the injection of the contrast agent into the ventricle. In each of our patients, 3 mL of ventricular CSF was immediately frozen and stored at −80°C until use for the orexin-A assay</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b8-nss-5-087">8</xref></citation_analysis></p>
      </sec>
      <sec>
        <title>Orexin-A assay</title>
        <p><citation_analysis attribute="positive">Orexin-A (hypocretin-1) was measured in crude CSF using a commercially available radioimmunoassay kit (Phoenix Pharmaceuticals, Belmont, CA, USA). The detection limit was 50 pg/mL, and intra-assay variability was 5%. Each CSF sample was tested in duplicate.</citation_analysis></p>
      </sec>
      <sec>
        <title>Statistics</title>
        <p><citation_analysis attribute="positive">Correlations between orexin-A levels and sleep parameters were evaluated using Spearman’s rank-correlation test and the nonparametric Mann-Whitney test. </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">-values smaller than 0.05 were considered significant.</citation_analysis></p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec sec-type="subjects">
        <title>Patients</title>
        <p><citation_analysis attribute="positive">We studied eight consecutive patients – four males and four females – whose clinical features are reported in </citation_analysis><citation_analysis attribute="positive"><xref ref-type="table" rid="t1-nss-5-087">Table 1</xref></citation_analysis><citation_analysis attribute="neither">. In all eight patients, surgery was performed under regional anesthesia between 10 am and 12 am.</citation_analysis></p>
        <p><citation_analysis attribute="positive">No patients or bed partners reported violent movements during sleep, although the spouse of patient #7 reported limb and body jerking.</citation_analysis></p>
      </sec>
      <sec>
        <title>Correlation between orexin-A levels and nighttime sleep parameters</title>
        <p><citation_analysis attribute="neither">Orexin-A levels did not correlate with total sleep time (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.23), REM duration (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.45), or REM latency (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="positive"> = 0.66). In contrast, orexin-A levels showed a significant positive correlation with the percentage of REM epochs without atonia, ie, percentage of 3-second mini-epochs classified as “any” (</citation_analysis><citation_analysis attribute="positive"><italic>ρ</italic></citation_analysis><citation_analysis attribute="neither"> = 0.83, </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.027) (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f1-nss-5-087">Figure 1A</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
        <p><citation_analysis attribute="neither">As previously described</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b6-nss-5-087">6</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b17-nss-5-087">17</xref></citation_analysis><citation_analysis attribute="positive"> RSWA is considered clinically significant when any submental EMG activity was present for more than 18% of the total REM sleep duration. According to this criterion, four of our patients had RSWA (#2, #3, #4, and #7). These four patients had higher median (interquartile range) orexin-A levels than the four patients with REM sleep atonia (235 pg/mL [215–345] vs 94 pg/mL [44–147]; Mann–Whitney test </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.036, </citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f1-nss-5-087">Figure 1B</xref></citation_analysis><citation_analysis attribute="neither">). No other sleep parameters differed significantly between these two groups of patients.</citation_analysis></p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p><citation_analysis attribute="positive">Our results show a significant relationship between ventricular CSF orexin-A levels and REM sleep characteristics in patients with PD. Despite the small number of patients, we found a correlation between orexin-A levels and RSWA. Our results suggest that orexin-A signaling may be associated with loss of muscle atonia during REM sleep in patients with PD.</citation_analysis></p>
      <p><citation_analysis attribute="neither">To our knowledge, this is the first study of potential correlations between ventricular CSF orexin-A levels and polysomnographic data in patients with PD. We undertook this study to investigate the physiological significance of altered orexin neurotransmission in PD, which has generated controversy.</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b12-nss-5-087">12</xref></citation_analysis><citation_analysis attribute="neither"> The strength of our study is the use of ventricular CSF. A previous study in PD patients found that ventricular CSF orexin levels correlated with the number of orexinergic neurons.</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b9-nss-5-087">9</xref></citation_analysis><citation_analysis attribute="positive"> Furthermore, while a lumbar CSF study failed to report a significant correlation between orexin levels and disease severity in a large group of 62 PD patients,</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b18-nss-5-087">18</xref></citation_analysis><citation_analysis attribute="positive"> a significant correlation was reported with ventricular samples.</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b8-nss-5-087">8</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">The main limitations of our study are the small number of patients and the absence of control subjects. We excluded patients taking sleep-altering medications and EMG activities concurrent with respiratory arousals,</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b19-nss-5-087">19</xref></citation_analysis><citation_analysis attribute="negative"> which may have further limited bias in our study.</citation_analysis></p>
      <p><citation_analysis attribute="neither">In our study, PD patients with higher ventricular CSF orexin levels exhibited larger numbers of RSWA epochs than did patients with lower orexin levels, suggesting that preserved orexin drive may be involved in loss of REM atonia. These results are congruent with experiments demonstrating that orexin neurons are strongly involved in muscle-tone control. Orexin neurons exert a facilitating influence on muscle tone, both directly via their projections on trigeminal motor neurons</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b20-nss-5-087">20</xref></citation_analysis><citation_analysis attribute="neither"> and spinal motor neurons</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b21-nss-5-087">21</xref></citation_analysis><citation_analysis attribute="neither"> and indirectly via the locus coeruleus neurons.</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b22-nss-5-087">22</xref></citation_analysis><citation_analysis attribute="neither"> Orexin injections into the locus coeruleus increase muscle tone</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b23-nss-5-087">23</xref></citation_analysis><citation_analysis attribute="neither"> and interrupt pedunculopontine nucleus-induced muscle atonia.</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b24-nss-5-087">24</xref></citation_analysis><citation_analysis attribute="neither"> However, regulation of muscle atonia relies on complex relationships and interactions between the orexin system, the locus coeruleus (in which orexin facilitates muscle activity), and the pontine inhibitory area (in which orexin inhibits muscle activity).</citation_analysis></p>
      <p><citation_analysis attribute="neither">Our results contrast with those obtained in narcolepsy-cataplexy, in which orexin levels negatively correlated with RSWA.</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b25-nss-5-087">25</xref></citation_analysis><citation_analysis attribute="positive"> However, narcolepsy-cataplexy and PD are two different diseases, and the process leading to orexinergic neuron loss is likely different. Orexin neurons are the primary target of an acute and specific neuronal aggression in narcolepsy, leading to a 90% reduction in the orexin neuron pool.</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b26-nss-5-087">26</xref></citation_analysis><citation_analysis attribute="neither"> In contrast, PD is a chronic, slowly progressive neurodegenerative disease, affecting primarily dopaminergic neurons, with a process not fully understood, leading to partial (23%–60%) orexin neuron loss.</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b10-nss-5-087">10</xref></citation_analysis><citation_analysis attribute="positive"> As an illustration, no cataplexy has been reported in PD patients, even in patients with undetectable orexin levels.</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b8-nss-5-087">8</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b12-nss-5-087">12</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Our results are also in contrast with a recent study that found similar orexin lumbar levels in five RBD patients.</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b27-nss-5-087">27</xref></citation_analysis><citation_analysis attribute="neither"> However, these patients had idiopathic RBD and no sign of PD.</citation_analysis></p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p><citation_analysis attribute="neither">The loss of REM atonia in patients with higher orexin levels illustrates the complexity of the symptoms induced by altered orexin neurotransmission in PD.</citation_analysis><citation_analysis attribute="positive"><xref ref-type="bibr" rid="b28-nss-5-087">28</xref></citation_analysis><citation_analysis attribute="neither"> Experimental trials of orexin antagonists could be of interest in the transgenic mouse model of RSWA.</citation_analysis></p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p><citation_analysis attribute="positive">
          </citation_analysis><citation_analysis attribute="positive"><bold>Disclosure</bold></citation_analysis><citation_analysis attribute="positive">
        </citation_analysis></p>
        <p><citation_analysis attribute="neither">The authors report no conflicts of interest in this work.</citation_analysis></p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="b1-nss-5-087">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garcia-Borreguero</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Larrosa</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Bravo</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Parkinson’s disease and sleep</article-title>
          <source>Sleep Med Rev</source>
          <year>2003</year>
          <volume>7</volume>
          <issue>2</issue>
          <fpage>115</fpage>
          <lpage>129</lpage>
          <pub-id pub-id-type="pmid">12628213</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-nss-5-087">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arnulf</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Konofal</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Merino-Andreu</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Parkinson’s disease and sleepiness: an integral part of PD</article-title>
          <source>Neurology</source>
          <year>2002</year>
          <volume>58</volume>
          <issue>7</issue>
          <fpage>1019</fpage>
          <lpage>1024</lpage>
          <pub-id pub-id-type="pmid">11940685</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-nss-5-087">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baumann</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ferini-Strambi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Waldvogel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Werth</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bassetti</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
          <article-title>Parkinsonism with excessive daytime sleepiness – a narcolepsy-like disorder?</article-title>
          <source>J Neurol</source>
          <year>2005</year>
          <volume>252</volume>
          <issue>2</issue>
          <fpage>139</fpage>
          <lpage>145</lpage>
          <pub-id pub-id-type="pmid">15729517</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-nss-5-087">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iranzo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Santamaría</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rye</surname>
              <given-names>DB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD</article-title>
          <source>Neurology</source>
          <year>2005</year>
          <volume>65</volume>
          <issue>2</issue>
          <fpage>247</fpage>
          <lpage>252</lpage>
          <pub-id pub-id-type="pmid">16043794</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-nss-5-087">
        <label>5</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>American Academy of Sleep Medicine</collab>
          </person-group>
          <source>The International Classification of Sleep Disorders: Diagnostic and Coding Manual</source>
          <edition>2nd ed</edition>
          <publisher-loc>Darien (IL)</publisher-loc>
          <publisher-name>American Academy of Sleep Medicine</publisher-name>
          <year>2005</year>
        </element-citation>
      </ref>
      <ref id="b6-nss-5-087">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gagnon</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Bédard</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Fantini</surname>
              <given-names>ML</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease</article-title>
          <source>Neurology</source>
          <year>2002</year>
          <volume>59</volume>
          <issue>4</issue>
          <fpage>585</fpage>
          <lpage>589</lpage>
          <pub-id pub-id-type="pmid">12196654</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-nss-5-087">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dauvilliers</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Arnulf</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Mignot</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Narcolepsy with cataplexy</article-title>
          <source>Lancet</source>
          <year>2007</year>
          <volume>369</volume>
          <issue>9560</issue>
          <fpage>499</fpage>
          <lpage>511</lpage>
          <pub-id pub-id-type="pmid">17292770</pub-id>
        </element-citation>
      </ref>
      <ref id="b8-nss-5-087">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drouot</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Moutereau</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>JP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Low levels of ventricular CSF orexin/hypocretin in advanced PD</article-title>
          <source>Neurology</source>
          <year>2003</year>
          <volume>61</volume>
          <issue>4</issue>
          <fpage>540</fpage>
          <lpage>543</lpage>
          <pub-id pub-id-type="pmid">12939433</pub-id>
        </element-citation>
      </ref>
      <ref id="b9-nss-5-087">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fronczek</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Overeem</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hypocretin (orexin) loss in Parkinson’s disease</article-title>
          <source>Brain</source>
          <year>2007</year>
          <volume>130</volume>
          <issue>Pt 6</issue>
          <fpage>1577</fpage>
          <lpage>1585</lpage>
          <pub-id pub-id-type="pmid">17470494</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-nss-5-087">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thannickal</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>YY</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Hypocretin (orexin) cell loss in Parkinson’s disease</article-title>
          <source>Brain</source>
          <year>2007</year>
          <volume>130</volume>
          <issue>Pt 6</issue>
          <fpage>1586</fpage>
          <lpage>1595</lpage>
          <pub-id pub-id-type="pmid">17491094</pub-id>
        </element-citation>
      </ref>
      <ref id="b11-nss-5-087">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drouot</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Moutereau</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lefaucheur</surname>
              <given-names>JP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Low level of ventricular CSF orexin-A is not associated with objective sleepiness in PD</article-title>
          <source>Sleep Med</source>
          <year>2011</year>
          <volume>12</volume>
          <issue>9</issue>
          <fpage>936</fpage>
          <lpage>937</lpage>
          <pub-id pub-id-type="pmid">21978722</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-nss-5-087">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baumann</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Scammell</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Bassetti</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
          <article-title>Parkinson’s disease, sleepiness and hypocretin/orexin</article-title>
          <source>Brain</source>
          <year>2008</year>
          <volume>131</volume>
          <issue>Pt 3</issue>
          <fpage>e91</fpage>
          <pub-id pub-id-type="pmid">17898005</pub-id>
        </element-citation>
      </ref>
      <ref id="b13-nss-5-087">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hughes</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Daniel</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Kilford</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lees</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>1992</year>
          <volume>55</volume>
          <issue>3</issue>
          <fpage>181</fpage>
          <lpage>184</lpage>
          <pub-id pub-id-type="pmid">1564476</pub-id>
        </element-citation>
      </ref>
      <ref id="b14-nss-5-087">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silber</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Ancoli-Israel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bonnet</surname>
              <given-names>MH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The visual scoring of sleep in adults</article-title>
          <source>J Clin Sleep Med</source>
          <year>2007</year>
          <volume>3</volume>
          <issue>2</issue>
          <fpage>121</fpage>
          <lpage>131</lpage>
          <pub-id pub-id-type="pmid">17557422</pub-id>
        </element-citation>
      </ref>
      <ref id="b15-nss-5-087">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Consens</surname>
              <given-names>FB</given-names>
            </name>
            <name>
              <surname>Chervin</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Koeppe</surname>
              <given-names>RA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Validation of a polysomnographic score for REM sleep behavior disorder</article-title>
          <source>Sleep</source>
          <year>2005</year>
          <volume>28</volume>
          <issue>8</issue>
          <fpage>993</fpage>
          <lpage>997</lpage>
          <pub-id pub-id-type="pmid">16218083</pub-id>
        </element-citation>
      </ref>
      <ref id="b16-nss-5-087">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lapierre</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Montplaisir</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Polysomnographic features of REM sleep behavior disorder: development of a scoring method</article-title>
          <source>Neurology</source>
          <year>1992</year>
          <volume>42</volume>
          <issue>7</issue>
          <fpage>1371</fpage>
          <lpage>1374</lpage>
          <pub-id pub-id-type="pmid">1620348</pub-id>
        </element-citation>
      </ref>
      <ref id="b17-nss-5-087">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frauscher</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Iranzo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gaig</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Normative EMG values during REM sleep for the diagnosis of REM sleep behavior disorder</article-title>
          <source>Sleep</source>
          <year>2012</year>
          <volume>35</volume>
          <issue>6</issue>
          <fpage>835</fpage>
          <lpage>847</lpage>
          <pub-id pub-id-type="pmid">22654203</pub-id>
        </element-citation>
      </ref>
      <ref id="b18-nss-5-087">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yasui</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kanbayashi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nomura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kusumi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakashima</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>CSF orexin levels of Parkinson’s disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration</article-title>
          <source>J Neurol Sci</source>
          <year>2006</year>
          <volume>250</volume>
          <issue>1–2</issue>
          <fpage>120</fpage>
          <lpage>123</lpage>
          <pub-id pub-id-type="pmid">17005202</pub-id>
        </element-citation>
      </ref>
      <ref id="b19-nss-5-087">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iranzo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Santamaria</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Severe obstructive sleep apnea/hypopnea mimicking REM sleep behavior disorder</article-title>
          <source>Sleep</source>
          <year>2005</year>
          <volume>28</volume>
          <issue>2</issue>
          <fpage>203</fpage>
          <lpage>206</lpage>
          <pub-id pub-id-type="pmid">16171244</pub-id>
        </element-citation>
      </ref>
      <ref id="b20-nss-5-087">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peever</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>YY</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Excitatory effects of hypocretin-1 (orexin-A) in the trigeminal motor nucleus are reversed by NMDA antagonism</article-title>
          <source>J Neurophysiol</source>
          <year>2003</year>
          <volume>89</volume>
          <issue>5</issue>
          <fpage>2591</fpage>
          <lpage>2600</lpage>
          <pub-id pub-id-type="pmid">12611960</pub-id>
        </element-citation>
      </ref>
      <ref id="b21-nss-5-087">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamuy</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fung</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Xi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chase</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>Hypocretinergic control of spinal cord motoneurons</article-title>
          <source>J Neurosci</source>
          <year>2004</year>
          <volume>24</volume>
          <issue>23</issue>
          <fpage>5336</fpage>
          <lpage>5345</lpage>
          <pub-id pub-id-type="pmid">15190106</pub-id>
        </element-citation>
      </ref>
      <ref id="b22-nss-5-087">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mileykovskiy</surname>
              <given-names>BY</given-names>
            </name>
            <name>
              <surname>Kiyashchenko</surname>
              <given-names>LI</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Muscle tone facilitation and inhibition after orexin-a (hypocretin-1) microinjections into the medial medulla</article-title>
          <source>J Neurophysiol</source>
          <year>2002</year>
          <volume>87</volume>
          <issue>5</issue>
          <fpage>2480</fpage>
          <lpage>2489</lpage>
          <pub-id pub-id-type="pmid">11976385</pub-id>
        </element-citation>
      </ref>
      <ref id="b23-nss-5-087">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kiyashchenko</surname>
              <given-names>LI</given-names>
            </name>
            <name>
              <surname>Mileykovskiy</surname>
              <given-names>BY</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>YY</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Increased and decreased muscle tone with orexin (hypocretin) microinjections in the locus coeruleus and pontine inhibitory area</article-title>
          <source>J Neurophysiol</source>
          <year>2001</year>
          <volume>85</volume>
          <issue>5</issue>
          <fpage>2008</fpage>
          <lpage>2016</lpage>
          <pub-id pub-id-type="pmid">11353017</pub-id>
        </element-citation>
      </ref>
      <ref id="b24-nss-5-087">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takakusaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Saitoh</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Orexinergic projections to the cat midbrain mediate alternation of emotional behavioral states from locomotion to cataplexy</article-title>
          <source>J Physiol</source>
          <year>2005</year>
          <volume>568</volume>
          <issue>Pt 3</issue>
          <fpage>1003</fpage>
          <lpage>1020</lpage>
          <pub-id pub-id-type="pmid">16123113</pub-id>
        </element-citation>
      </ref>
      <ref id="b25-nss-5-087">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Knudsen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gammeltoft</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jennum</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency</article-title>
          <source>Brain</source>
          <year>2010</year>
          <volume>133</volume>
          <issue>Pt 2</issue>
          <fpage>568</fpage>
          <lpage>579</lpage>
          <pub-id pub-id-type="pmid">20129934</pub-id>
        </element-citation>
      </ref>
      <ref id="b26-nss-5-087">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thannickal</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>RY</given-names>
            </name>
            <name>
              <surname>Nienhuis</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reduced number of hypocretin neurons in human narcolepsy</article-title>
          <source>Neuron</source>
          <year>2000</year>
          <volume>27</volume>
          <issue>3</issue>
          <fpage>469</fpage>
          <lpage>474</lpage>
          <pub-id pub-id-type="pmid">11055430</pub-id>
        </element-citation>
      </ref>
      <ref id="b27-nss-5-087">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Vincent</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>IE</given-names>
            </name>
            <name>
              <surname>Shneerson</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Cerebrospinal fluid hypocretin levels are normal in idiopathic REM sleep behaviour disorder</article-title>
          <source>Eur J Neurol</source>
          <year>2010</year>
          <volume>17</volume>
          <issue>8</issue>
          <fpage>1105</fpage>
          <lpage>1107</lpage>
          <pub-id pub-id-type="pmid">20113337</pub-id>
        </element-citation>
      </ref>
      <ref id="b28-nss-5-087">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fronczek</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Baumann</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Lammers</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Bassetti</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Overeem</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Hypocretin/orexin disturbances in neurological disorders</article-title>
          <source>Sleep Med Rev</source>
          <year>2009</year>
          <volume>13</volume>
          <issue>1</issue>
          <fpage>9</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="pmid">18819824</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-nss-5-087" position="float">
      <label>Figure 1</label>
      <caption>
        <p><citation_analysis attribute="neither">(</citation_analysis><citation_analysis attribute="positive"><bold>A</bold></citation_analysis><citation_analysis attribute="neither">) Association between ventricular orexin-A levels (pg/mL) and loss of rapid-eye-movement (REM) atonia. (</citation_analysis><citation_analysis attribute="positive"><bold>B</bold></citation_analysis><citation_analysis attribute="neither">) Orexin-A levels (pg/mL) based on the percentage of REM without atonia.</citation_analysis></p>
        <p><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="neither"> (</citation_analysis><citation_analysis attribute="positive"><bold>A</bold></citation_analysis><citation_analysis attribute="neither">) Plot of the percentage of REM sleep mini-epochs without atonia (using “any” electromyographic activity) and orexin-A levels for each patient (</citation_analysis><citation_analysis attribute="positive"><bold>B</bold></citation_analysis><citation_analysis attribute="neither">) Orexin-A levels in patients with less than 18% (n = 4, left) and in patients with more than 18% (n = 4, right) of REM epochs without atonia. Horizontal black bars represent median values for each group. *</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05.</citation_analysis></p>
      </caption>
      <graphic xlink:href="nss-5-087Fig1"/>
    </fig>
    <table-wrap id="t1-nss-5-087" position="float">
      <label>Table 1</label>
      <caption>
        <p><citation_analysis attribute="neither">Nighttime sleep parameters</citation_analysis></p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left" valign="top" rowspan="1" colspan="1"/>
            <th align="left" valign="top" rowspan="1" colspan="1">#1, F</th>
            <th align="left" valign="top" rowspan="1" colspan="1">#2, F</th>
            <th align="left" valign="top" rowspan="1" colspan="1">#3, F</th>
            <th align="left" valign="top" rowspan="1" colspan="1">#4, F</th>
            <th align="left" valign="top" rowspan="1" colspan="1">#5, M</th>
            <th align="left" valign="top" rowspan="1" colspan="1">#6, M</th>
            <th align="left" valign="top" rowspan="1" colspan="1">#7, M</th>
            <th align="left" valign="top" rowspan="1" colspan="1">#8, M</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Age, years</td>
            <td align="left" valign="top" rowspan="1" colspan="1">62</td>
            <td align="left" valign="top" rowspan="1" colspan="1">66</td>
            <td align="left" valign="top" rowspan="1" colspan="1">52</td>
            <td align="left" valign="top" rowspan="1" colspan="1">52</td>
            <td align="left" valign="top" rowspan="1" colspan="1">69</td>
            <td align="left" valign="top" rowspan="1" colspan="1">48</td>
            <td align="left" valign="top" rowspan="1" colspan="1">63</td>
            <td align="left" valign="top" rowspan="1" colspan="1">54</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Disease duration (years)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">13</td>
            <td align="left" valign="top" rowspan="1" colspan="1">18</td>
            <td align="left" valign="top" rowspan="1" colspan="1">15</td>
            <td align="left" valign="top" rowspan="1" colspan="1">8</td>
            <td align="left" valign="top" rowspan="1" colspan="1">7</td>
            <td align="left" valign="top" rowspan="1" colspan="1">12</td>
            <td align="left" valign="top" rowspan="1" colspan="1">18</td>
            <td align="left" valign="top" rowspan="1" colspan="1">11</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Sleep latency (minutes)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">45</td>
            <td align="left" valign="top" rowspan="1" colspan="1">10</td>
            <td align="left" valign="top" rowspan="1" colspan="1">46.5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">16.7</td>
            <td align="left" valign="top" rowspan="1" colspan="1">66.5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">10.5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">24</td>
            <td align="left" valign="top" rowspan="1" colspan="1">20</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Sleep efficiency (%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">89</td>
            <td align="left" valign="top" rowspan="1" colspan="1">78</td>
            <td align="left" valign="top" rowspan="1" colspan="1">50.3</td>
            <td align="left" valign="top" rowspan="1" colspan="1">80.2</td>
            <td align="left" valign="top" rowspan="1" colspan="1">45.3</td>
            <td align="left" valign="top" rowspan="1" colspan="1">77</td>
            <td align="left" valign="top" rowspan="1" colspan="1">84</td>
            <td align="left" valign="top" rowspan="1" colspan="1">80</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">TST (minutes)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">413</td>
            <td align="left" valign="top" rowspan="1" colspan="1">375</td>
            <td align="left" valign="top" rowspan="1" colspan="1">311</td>
            <td align="left" valign="top" rowspan="1" colspan="1">385</td>
            <td align="left" valign="top" rowspan="1" colspan="1">269</td>
            <td align="left" valign="top" rowspan="1" colspan="1">360</td>
            <td align="left" valign="top" rowspan="1" colspan="1">467</td>
            <td align="left" valign="top" rowspan="1" colspan="1">346</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Stage N2 (minutes)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">41</td>
            <td align="left" valign="top" rowspan="1" colspan="1">60</td>
            <td align="left" valign="top" rowspan="1" colspan="1">44</td>
            <td align="left" valign="top" rowspan="1" colspan="1">70</td>
            <td align="left" valign="top" rowspan="1" colspan="1">40</td>
            <td align="left" valign="top" rowspan="1" colspan="1">49</td>
            <td align="left" valign="top" rowspan="1" colspan="1">43</td>
            <td align="left" valign="top" rowspan="1" colspan="1">47</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Stage N3 (minutes)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">111</td>
            <td align="left" valign="top" rowspan="1" colspan="1">49</td>
            <td align="left" valign="top" rowspan="1" colspan="1">67</td>
            <td align="left" valign="top" rowspan="1" colspan="1">32</td>
            <td align="left" valign="top" rowspan="1" colspan="1">83</td>
            <td align="left" valign="top" rowspan="1" colspan="1">82</td>
            <td align="left" valign="top" rowspan="1" colspan="1">110</td>
            <td align="left" valign="top" rowspan="1" colspan="1">104</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">REM (%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">24</td>
            <td align="left" valign="top" rowspan="1" colspan="1">20</td>
            <td align="left" valign="top" rowspan="1" colspan="1">21</td>
            <td align="left" valign="top" rowspan="1" colspan="1">7</td>
            <td align="left" valign="top" rowspan="1" colspan="1">17</td>
            <td align="left" valign="top" rowspan="1" colspan="1">26</td>
            <td align="left" valign="top" rowspan="1" colspan="1">28</td>
            <td align="left" valign="top" rowspan="1" colspan="1">14</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">REM latency (minutes)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">115</td>
            <td align="left" valign="top" rowspan="1" colspan="1">65</td>
            <td align="left" valign="top" rowspan="1" colspan="1">112</td>
            <td align="left" valign="top" rowspan="1" colspan="1">95</td>
            <td align="left" valign="top" rowspan="1" colspan="1">128</td>
            <td align="left" valign="top" rowspan="1" colspan="1">216</td>
            <td align="left" valign="top" rowspan="1" colspan="1">109</td>
            <td align="left" valign="top" rowspan="1" colspan="1">64</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">3-second REM epochs with any activity (%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">6</td>
            <td align="left" valign="top" rowspan="1" colspan="1">37</td>
            <td align="left" valign="top" rowspan="1" colspan="1">19</td>
            <td align="left" valign="top" rowspan="1" colspan="1">43</td>
            <td align="left" valign="top" rowspan="1" colspan="1">5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">6</td>
            <td align="left" valign="top" rowspan="1" colspan="1">33</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">AHI (events/hour)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">7</td>
            <td align="left" valign="top" rowspan="1" colspan="1">2</td>
            <td align="left" valign="top" rowspan="1" colspan="1">8</td>
            <td align="left" valign="top" rowspan="1" colspan="1">3</td>
            <td align="left" valign="top" rowspan="1" colspan="1">7</td>
            <td align="left" valign="top" rowspan="1" colspan="1">10</td>
            <td align="left" valign="top" rowspan="1" colspan="1">9</td>
            <td align="left" valign="top" rowspan="1" colspan="1">10</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">PLMs (events/hour)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">2</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">17</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Fragmentation (events/hour)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">20</td>
            <td align="left" valign="top" rowspan="1" colspan="1">27</td>
            <td align="left" valign="top" rowspan="1" colspan="1">21</td>
            <td align="left" valign="top" rowspan="1" colspan="1">28</td>
            <td align="left" valign="top" rowspan="1" colspan="1">18</td>
            <td align="left" valign="top" rowspan="1" colspan="1">9</td>
            <td align="left" valign="top" rowspan="1" colspan="1">11</td>
            <td align="left" valign="top" rowspan="1" colspan="1">12</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Orexin-A (pg/mL)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">50</td>
            <td align="left" valign="top" rowspan="1" colspan="1">240</td>
            <td align="left" valign="top" rowspan="1" colspan="1">200</td>
            <td align="left" valign="top" rowspan="1" colspan="1">230</td>
            <td align="left" valign="top" rowspan="1" colspan="1">138</td>
            <td align="left" valign="top" rowspan="1" colspan="1">156</td>
            <td align="left" valign="top" rowspan="1" colspan="1">450</td>
            <td align="left" valign="top" rowspan="1" colspan="1">39</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tfn1-nss-5-087">
          <p><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="neither"> Sleep latency was nighttime sleep latency of the first N2 epoch; sleep stage N3 is slow-wave sleep; any activity/REM was calculated as percentage of 3-second REM epochs with “any” activity.</citation_analysis></p>
        </fn>
        <fn id="tfn2-nss-5-087">
          <p><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="neither"> TST, total sleep time; REM, rapid eye movement; AHI, apnea/hypopnea index; PLMs, periodic limb movements; F, female; M, male.</citation_analysis></p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
